Tower Research Capital (TRC)’s OmniAb OABI Stock Holding History
Bought
Maintained
Sold
Other funds holding OABI
WCM
CCM
VCM
RHJA
PMG
TL
Tower Research Capital (TRC)'s OABI Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its OmniAb (OABI) stake by 463% in Q1 2026, buying an estimated $52.4K and bringing the position to 35,306 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.
Tower Research Capital (TRC) first reported a position in OABI in Q4 2021 and has held it in 16 quarters since. The position peaked at $146K in Q3 2023. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.
- Tower Research Capital (TRC) held 35,306 shares of OmniAb worth $55.4K as of Q1 2026.
- Tower Research Capital (TRC) bought 29,036 OmniAb shares in Q1 2026, an estimated $52.4K.
- OmniAb made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2655 holding.
- Tower Research Capital (TRC) first reported a position in OmniAb in Q4 2021 and has held it in 16 quarters since.
- Tower Research Capital (TRC)'s OmniAb position peaked at $146K in Q3 2023.
- 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.